Filing Details
- Accession Number:
- 0001127602-17-017792
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-11 18:14:15
- Reporting Period:
- 2017-05-09
- Filing Date:
- 2017-05-11
- Accepted Time:
- 2017-05-11 18:14:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1319872 | Francis John Cogan | 333 Lakeside Drive Foster City CA 94404 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-09 | 1,787 | $0.00 | 47,562 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-05-09 | 15,000 | $20.71 | 62,562 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-09 | 9,943 | $67.25 | 52,619 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2017-05-09 | 1,787 | $0.00 | 1,787 | $0.00 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2017-05-09 | 15,000 | $0.00 | 15,000 | $20.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 0 | 2017-05-09 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- 100% of the restricted stock units vested on May 9, 2017.
- The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- Options are 100% vested on the date of grant.
Billionaire Hedge Funds
